For example, knocking down MLL1 markedly decreased tumor cell growth, and pharmacological inhibition of the MLL1 methyltransferase complex inhibited proliferation of cancer cells carrying p53 mutations, but did not affect those without p53 mutants [73]. This evidence concerns the gene KMT2A and cancer.